| |
 |
Collaborations
ReceptIcon is participating in a large EU consortium of 18 partners
from academic research institutions and university hospitals in 9
countries that aims to identify major mechanisms (both genetic and
environmental) that are responsible for kidney diseases. ReceptIcon
acts as the Small Medium Enterprise (SME) partner in this consortium.
The collaboration provides the company with access to studies performed
by the most distinguished scientists and clinicians in Europe within
the field of kidney diseases, based at the Medical Research Council
(UK), INSERM (France) and HGF (Germany), as well as the Universities
of Paris, Oxford or the ETH Zurich just to name a few.
Professor Thomas Willnow, co-founder of ReceptIcon, coordinates this
consortium. |